Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
| Autor: | D. Schonholz, F. P. Siegal, Vincent R. Zurawski, Robert C. Bast, Thomas L. Klug, Robert C. Knapp, Carolyn D. Runowicz, C. J. Cohen |
|---|---|
| Rok vydání: | 1985 |
| Předmět: |
Pathology
medicine.medical_specialty Time Factors Anticorps monoclonal medicine.drug_class Early detection CA 15-3 Ovary Monoclonal antibody Malignancy Epitopes Agammaglobulinemia Antigens Neoplasm Humans Medicine Antigens Tumor-Associated Carbohydrate Ovarian Neoplasms business.industry Obstetrics and Gynecology Middle Aged medicine.disease medicine.anatomical_structure Oncology Epithelial ovarian carcinoma Female business Ovarian cancer |
| Zdroj: | Gynecologic Oncology. 22:115-120 |
| ISSN: | 0090-8258 |
| DOI: | 10.1016/0090-8258(85)90015-0 |
| Popis: | In a single fortuitous case it has been possible to measure serum levels of CA 125 during 3 years preceding the diagnosis of an epithelial ovarian carcinoma. CA 125 levels were elevated 10–12 months prior to clinical detection of the malignancy. CA 125 deserves further evaluation as a marker for early detection of ovarian cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|